CISPLATIN NEPHROTOXICITY: THE EFFECT OF DOSE, SCHEDULE, AND HYDRATION SCHEME
- 1 January 1980
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Cisplatin, bleomycin, and vinblastine combination therapy of testicular tumors: An analysisMedical and Pediatric Oncology, 1979
- Weekly administration of cis-diamminedichloroplatinum (II) without hydration or osmotic diuresisPublished by Elsevier ,1978
- Treatment of Advanced Bladder Cancer with Cis-Diamminedichloroplatinum (II NSC 119875): A Pilot StudyJournal of Urology, 1978
- Nephrotoxicity of cis‐platinum (II) dichlorodiammineClinical Pharmacology & Therapeutics, 1978
- Safe, rapid administration schedule for cis-platinum—mannitolMedical and Pediatric Oncology, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Improvement of Cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal modelCancer, 1977
- High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresisCancer, 1977
- Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumorsCancer, 1974
- Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)Cancer, 1972